| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood in the bookshop
|
Ranscombe, Peter
|
|
2016
|
3 |
5 |
p. e214-
1 p.
|
artikel
|
| 2 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
|
Ferreri, Andrés J M
|
|
2016
|
3 |
5 |
p. e217-e227
nvt p.
|
artikel
|
| 3 |
Defining optimal initial therapy for primary CNS lymphoma
|
Schiff, David
|
|
2016
|
3 |
5 |
p. e206-e207
nvt p.
|
artikel
|
| 4 |
Edoxaban in the secondary prevention of VTE
|
Levy, Jerrold H
|
|
2016
|
3 |
5 |
p. e208-e209
nvt p.
|
artikel
|
| 5 |
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
|
Mariotte, Eric
|
|
2016
|
3 |
5 |
p. e237-e245
nvt p.
|
artikel
|
| 6 |
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
|
Raskob, Gary
|
|
2016
|
3 |
5 |
p. e228-e236
nvt p.
|
artikel
|
| 7 |
Is complete remission key in elderly patients with AML?
|
Ferrara, Felicetto
|
|
2016
|
3 |
5 |
p. e212-e213
nvt p.
|
artikel
|
| 8 |
42nd Annual Meeting of the European Society for Blood and Marrow Transplantation
|
Smith, Lan-Lan
|
|
2016
|
3 |
5 |
p. e215-e216
nvt p.
|
artikel
|
| 9 |
Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study
|
Heddle, Nancy M
|
|
2016
|
3 |
5 |
p. e246-e254
nvt p.
|
artikel
|
| 10 |
Straying from the target
|
The Lancet Haematology,
|
|
2016
|
3 |
5 |
p. e205-
1 p.
|
artikel
|
| 11 |
Thrombotic thrombocytopenic purpura: gaining knowledge
|
Bennett, Charles L
|
|
2016
|
3 |
5 |
p. e210-e211
nvt p.
|
artikel
|
Tijdschrift beschrijving